The burden of serious fungal disease in the UK – infections with “rare” organisms

In the absence of mandatory surveillance programs for individual fungal organisms, attempts to determine the burden of fungal disease commonly rely upon methods that estimate infection rates based on incidence data for specific at-risk populations, coupled with anecdotal data from mycology referral centres.1-3 A recent study published in this journal provided crude estimates of the annual incidence of Pneumocystis pneumonia, cryptococcal disease, invasive aspergillosis, chronic pulmonary aspergillosis, allergic bronchopulmonary aspergillosis, severe asthma with fungal sensitisation, candidemia, oesophageal candidosis, Candida peritonitis and mucoromycosis in the United Kingdom (UK) using such approaches. (Source: Journal of Infection)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2SBeoiA